President Trump recently stated he was taking hydroxychloroquine, an anti-malaria drug that has been unproven to prevent or treat infection of COVID-19. Trump has touted the drug over the past several weeks for benefitting COVID-19 patients, but studies have shown little to no impact.

Such was the case in 2009, when the Great Recession brought about a “protracted, seven-year struggle” to recruit medical students into the specialty, experts wrote in Current Problems in Diagnostic Radiology. 

U.S. healthcare leadership missed opportunities for optimally promoting public health fairly early on in the present pandemic.

Inflitration occurs when a a radiotracer is not safely injected into an individual's vein, but the true impact of these adverse events remains unknown to patients and physicians.

How should nonculprit lesions be evaluated? And when is the ideal time for complete revascularization?

Johns Hopkins has scored a $195,000 grant from the National Science Foundation, with its scientists now beginning the first phase of the one-year research project.

Notching its fifth go-ahead from the FDA, an Israel-based AI startup has received the agency’s 510(k) clearance to market software that automatically identifies signs of compression fractures in the spine.

Heart and lung surgeons are as satisfied with their jobs as ever, according to new survey results published in The Annals of Thoracic Surgery.

The more than 19,000 users of the Colorado Regional Health Information Organization can now quickly share images, regardless of provider or electronic health record.

Americans are delaying critical stroke care as a result of the ongoing COVID-19 pandemic by not dialing 9-1-1 when they are experiencing a stroke.